Obesity not only leads to tumour progression, immune ageing and PD‐1‐mediated T cell dysfunction but also is linked to enhanced efficacy of PD‐1/PD‐L1 inhibitors [35]. The gene discussed is CD274; the disease is obesity due to melanocortin 4 receptor deficiency.